National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 3410-3411 [2024-00896]
Download as PDF
<![CDATA[
3410
Federal Register / Vol. 89, No. 12 / Thursday, January 18, 2024 / Notices
respondents can read and click faster
than a phone interviewer can read
survey questions.
Burden in this context means the time
expended by persons to generate,
maintain, retain, disclose, or provide the
information requested. This includes
the time needed to review instructions;
to develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Form name
The National Survey of Organ Donation Attitudes and Practices
(NSODAP)—Telephone (English and Spanish versions) ..................
The National Survey of Organ Donation Attitudes and Practices
(NSODAP)—Web (English and Spanish versions) ............................
Total ................................................................................................
HRSA specifically requests comments
on: (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–00819 Filed 1–17–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
VerDate Sep<11>2014
17:32 Jan 17, 2024
Jkt 262001
Number of
responses per
respondent
2,000
1
2,000
0.37
740
8,000
1
8,000
0.27
2,160
10,000
........................
10,000
....................
2,900
Emphasis Panel; T90/R90 Interdisciplinary
Training Awards in Clinical Pain Research
(RFA–NS–24–015).
Date: February 12, 2024.
Time: 9:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Steven G. Britt, Scientific
Review Officer, Scientific Review Branch,
Division of Extramural Activities, NINDS/
NIH, NSC, 6001 Executive Blvd., Rockville,
MD 20852, 301–480–1953, steve.britt@
nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Initial Translation Efforts for
Non-addictive Analgesic Therapeutics
Development (HEAL U19).
Date: February 13–14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Abhignya Subedi, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Rockville, MD 20852, 301–496–9223,
abhi.subedi@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; HEAL Initiative: Planning
Studies for Initial Analgesic Development
[Small Molecules and Biologics] (R61
Clinical Trial Not Allowed).
Date: February 16, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
PO 00000
Frm 00041
Fmt 4703
Average
burden per
response
(in hours)
Number of
respondents
Sfmt 4703
Total
responses
Total
burden
hours
Contact Person: Bo-Shiun Chen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Rockville, MD 20852, 301–496–9223, boshiun.chen@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R25 Review.
Date: February 22, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Lataisia Cherie Jones,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH, 6001 Executive
Blvd., Rockville, MD 20852, 301–496–9223,
lataisia.jones@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Research Opportunities in
the Human Brain (ROH) U01/R61.
Date: February 26–27, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Tatiana Pasternak, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NSC, 6001 Executive Blvd., NINDS/NIH,
Rockville, MD 20852, 301–496–9223,
tatiana.pasternak@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
E:\FR\FM\18JAN1.SGM
18JAN1
Federal Register / Vol. 89, No. 12 / Thursday, January 18, 2024 / Notices
Dated: January 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00896 Filed 1–17–24; 8:45 am]
DEPARTMENT OF THE INTERIOR
National Institutes of Health
[Docket No. FWS–R6–ES–2023–0203;
FXES11130600000–223–FF06E00000]
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Eunice Kennedy
Shriver National Institute of Child Health
and Human Development Special Emphasis
Panel; Implementation Science Coordinating
Center for HIV-affected Adolescents.
Date: March 26, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Eunice
Kennedy Shriver, National Institute of Child
Health and Human Development, 6710B
Rockledge Drive, Bethesda, MD 20817,
(Virtual Meeting).
Contact Person: Magnus A. Azuine, Ph.D.,
Scientific Review Branch, Eunice Kennedy
Shriver, National Institute of Child Health &
Human Development, NIH, 6710B Rockledge
Drive, Room 2125C, Bethesda, MD 20817,
(301) 480–4645, magnus.azuine@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Eunice Kennedy
Shriver National Institute of Child Health
and Human Development Special Emphasis
Panel; Member Conflict: Function, and
Rehabilitation Sciences Study Section.
Date: March 5, 2024.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Eunice
Kennedy Shriver, National Institute of Child
Health and Human Development, 6710B
Rockledge Drive, Bethesda, MD 20817,
(Virtual Meeting).
Contact Person: Magnus A. Azuine, Ph.D.,
Scientific Review Branch, Eunice Kennedy
Shriver, National Institute of Child Health &
Human Development, NIH, 6710B Rockledge
Drive, Room 2125C, Bethesda, MD 20817,
(301) 480–4645, magnus.azuine@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: January 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00899 Filed 1–17–24; 8:45 am]
BILLING CODE 4140–01–P
Dated: January 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00900 Filed 1–17–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:32 Jan 17, 2024
Jkt 262001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
3411
Fish and Wildlife Service
Endangered and Threatened Wildlife
and Plants; Establishment of an
Experimental Population of the Grizzly
Bear in the Bitterroot Ecosystem of the
States of Idaho and Montana;
Environmental Impact Statement
Fish and Wildlife Service,
Interior.
ACTION: Notification of intent,
announcement of public meetings, and
request for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service (Service), intend to
prepare an environmental impact
statement (EIS) under the National
Environmental Policy Act of 1969, as
amended, to evaluate the potential
environmental impacts of restoring the
grizzly bear (Ursus arctos horribilis) to
the Bitterroot Ecosystem (BE), a portion
of the species’ historical range, in
Montana and Idaho. We previously
issued a final EIS, record of decision,
and final rule under section 10(j) of the
Endangered Species Act of 1973, as
amended, to reintroduce grizzly bears to
the BE as a nonessential experimental
population. However, conditions have
changed, so we intend to reevaluate a
range of options to restore the grizzly
bear to the BE during the development
of a new EIS. We invite input from other
Federal and State agencies, Tribes,
nongovernmental organizations, privatesector businesses, and members of the
public on the scope of the EIS,
alternatives to our proposed approaches
for assisting in the restoration of the
grizzly bear in the BE, and the pertinent
issues that we should address in the
EIS. We also invite the public and
interested parties to attend virtual
public scoping meetings.
DATES:
Comment submission: We will accept
comments received or postmarked on or
before March 18, 2024. Comments
submitted electronically using the
Federal eRulemaking Portal (see
ADDRESSES, below) must be received by
11:59 p.m. eastern time on the closing
date.
Public scoping meetings: We will host
at least two virtual public scoping
meetings to share information regarding
the development of the draft EIS and
allow the public to ask questions
regarding the scope of issues and the
proposed alternatives. We will
announce the dates, times, and details
of these virtual public scoping meetings
SUMMARY:
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 89, Number 12 (Thursday, January 18, 2024)]
[Notices]
[Pages 3410-3411]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00896]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; T90/R90 Interdisciplinary
Training Awards in Clinical Pain Research (RFA-NS-24-015).
Date: February 12, 2024.
Time: 9:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Steven G. Britt, Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH, NSC, 6001 Executive Blvd., Rockville, MD 20852, 301-480-1953,
[email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Initial Translation Efforts for
Non-addictive Analgesic Therapeutics Development (HEAL U19).
Date: February 13-14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Abhignya Subedi, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive Blvd., Rockville, MD
20852, 301-496-9223, [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; HEAL Initiative: Planning Studies
for Initial Analgesic Development [Small Molecules and Biologics]
(R61 Clinical Trial Not Allowed).
Date: February 16, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Bo-Shiun Chen, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH, NSC, 6001 Executive Blvd., Rockville, MD 20852, 301-496-9223,
[email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; R25 Review.
Date: February 22, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Lataisia Cherie Jones, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, 6001 Executive Blvd., Rockville, MD 20852,
301-496-9223, [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Research Opportunities in the
Human Brain (ROH) U01/R61.
Date: February 26-27, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Tatiana Pasternak, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NSC, 6001 Executive Blvd., NINDS/NIH, Rockville, MD
20852, 301-496-9223, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
[[Page 3411]]
Dated: January 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00896 Filed 1-17-24; 8:45 am]
BILLING CODE 4140-01-P
